Advertisement.

OCS Projected Dividend Yield

Oculis Holding AG ( NASDAQ : OCS )

Oculis Holding is a clinical-stage biopharmaceutical company, engaged in the development of drug candidates to address eye-related conditions. Co.'s clinical portfolio includes: OCS-01, which is being evaluated for the treatment of diabetic macular edema and for the treatment of inflammation and pain following cataract surgery; OCS-02, which is a treatment for keratoconjunctivitis sicca, or dry eye disease and a treatment for non-infectious anterior uveitis; and OCS-05, which is a neuroprotective agent with potential application in multiple indications, including glaucoma, geographic atrophy, diabetic retinopathy and neurotrophic keratitis.

20 YEAR PERFORMANCE RESULTS

OCS Dividend History Detail
OCS Dividend News
OCS Competitors News

# of Shares: 0

Closing Price: 11.98

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000